Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Three monoclonal antibodies - aducanumab , lecanemab , and donanemab - against Amyloid-beta (Aß, Abeta) / Amyloid Plaques in the brain slow cognitive and functional decline in early-stage Alzheimer's Disease (AD)
However, targeting Amyloid-beta (Aß, Abeta) / Amyloid Plaques in the symp…